St. Jude Medical, Inc. (STJ) Issues Q4 Earnings Guidance
St. Jude Medical, Inc. (STJ) issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.86-0.88 for the period.
Shares of St. Jude Medical, Inc. (STJ) traded down 6.03% during mid-day trading on Wednesday, hitting $40.35. St. Jude Medical, Inc. (STJ) has a one year low of $32.13 and a one year high of $44.80. The company has a market cap of $12.669 billion and a P/E ratio of 17.03.
St. Jude Medical last issued its quarterly earnings data on Wednesday, October 17th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company’s quarterly revenue was down 4.1% on a year-over-year basis. On average, analysts predict that St. Jude Medical, Inc. (STJ) will post $3.43 earnings per share for the current fiscal year.
STJ has been the subject of a number of recent research reports. Analysts at Jefferies Group reiterated a hold rating on shares of St. Jude Medical in a research note to investors on Friday, October 12th. They now have a $40.00 price target on the stock. On a related note, analysts at Wells Fargo & Co. reiterated an outperform rating on shares of St. Jude Medical in a research note to investors on Friday, October 5th. Finally, analysts at JMP Securities reiterated a market perform rating on shares of St. Jude Medical in a research note to investors on Monday, October 1st.
St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.